HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Edgar Bautista Selected Research

volagidemab

1/2018Effect of a glucagon receptor antibody (REMD-477) in type 1 diabetes: A randomized controlled trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Edgar Bautista Research Topics

Disease

4Human Influenza (Influenza)
06/2013 - 08/2009
3Infections
12/2014 - 08/2009
2Critical Illness (Critically Ill)
12/2014 - 11/2009
2Pneumonia (Pneumonitis)
01/2011 - 08/2009
1Anthrax
10/2021
1Migraine Disorders (Migraine)
01/2018
1Type 1 Diabetes Mellitus (Autoimmune Diabetes)
01/2018
1Obesity
12/2014
1Acute Kidney Injury (Acute Renal Failure)
12/2014
1Inflammation (Inflammations)
05/2014
1Respiratory Hypersensitivity
05/2014
1Asthma (Bronchial Asthma)
05/2014
1Psoriasis (Pustulosis Palmaris et Plantaris)
04/2014
1Insulin Resistance
06/2011
1Viral Pneumonia
01/2011
1Respiratory Insufficiency (Respiratory Failure)
04/2010
1Hypoxia (Hypoxemia)
11/2009
1Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome)
11/2009
1Dyspnea (Shortness of Breath)
08/2009
1Lymphopenia (Lymphocytopenia)
08/2009
1Cough
08/2009
1Fever (Fevers)
08/2009
1Thrombosis (Thrombus)
01/2007
1Emphysema
02/2004
1Sepsis (Septicemia)
09/2002
1Septic Shock (Toxic Shock Syndrome)
09/2002
1Shock
06/2002
1Anaphylaxis (Anaphylactic Shock)
06/2002
1Bacteremia
03/2002

Drug/Important Bio-Agent (IBA)

2Insulin (Novolin)FDA Link
01/2018 - 12/2014
2CytokinesIBA
05/2014 - 06/2013
2Oseltamivir (Tamiflu)FDA Link
01/2011 - 08/2009
2Creatine Kinase (Creatine Phosphokinase)IBA
11/2009 - 08/2009
1Neutralizing AntibodiesIBA
10/2021
1Monoclonal AntibodiesIBA
01/2018
1volagidemabIBA
01/2018
1erenumabIBA
01/2018
1Capsaicin (Zostrix)FDA Link
01/2018
1Glucagon Receptors (Glucagon Receptor)IBA
01/2018
1Calcitonin Gene-Related PeptideIBA
01/2018
1Tissue Plasminogen Activator (Alteplase)FDA Link
12/2014
1ProcalcitoninIBA
12/2014
1Acute-Phase Proteins (Acute-Phase Protein)IBA
12/2014
1C-PeptideIBA
12/2014
1C-Reactive ProteinIBA
12/2014
1LeptinIBA
12/2014
1Glucagon (Glukagon)FDA Link
12/2014
1AllergensIBA
05/2014
1Thymic Stromal LymphopoietinIBA
05/2014
1Nitric Oxide (Nitrogen Monoxide)FDA Link
05/2014
1brodalumabIBA
04/2014
1Interleukin-17 (Interleukin 17)IBA
04/2014
1LigandsIBA
04/2014
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
06/2013
1ChemokinesIBA
06/2013
1Glucose (Dextrose)FDA LinkGeneric
06/2011
1Antiviral Agents (Antivirals)IBA
01/2011
1Oxygen (Dioxygen)IBA
11/2009
1CreatinineIBA
11/2009
1RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
08/2009
1L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
08/2009
1PapainIBA
02/2004
1Sodium Bicarbonate (Baking Soda)FDA LinkGeneric
09/2002
1Lactic Acid (Lactate)FDA LinkGeneric
09/2002
1Sodium LactateFDA LinkGeneric
09/2002
1AlkaliesIBA
09/2002
1ML 9IBA
06/2002
1Epinephrine (Adrenaline)FDA LinkGeneric
06/2002
1Histamine H3 Receptors (Histamine H3 Receptor)IBA
03/2002

Therapy/Procedure

2Artificial Respiration (Mechanical Ventilation)
01/2011 - 11/2009
1Critical Care (Surgical Intensive Care)
04/2010
1Length of Stay
11/2009
1Embolectomy
01/2007
1Pneumonectomy (Lung Volume Reduction)
02/2004
1Catheters
09/2002
1Intravenous Infusions
03/2002